Journal of Drugs in Dermatology

View more issues:

Articles in Sept, 2006 issue of Journal of Drugs in Dermatology

• Rhytides, laxity, and photoaging treated with a combination of radiofrequency, diode laser, and pulsed light and assessed with a comprehensive grading scale
  by Macrene Alexiades-Armenakas
• Etanercept and recalcitrant acrodermatitis continua of Hallopeau
  by Arjen F. Nikkels
• Multicenter clinical perspectives on a broadband infrared light device for skin tightening
  by Amy Forman Taub
• FDA approves merck's cervical cancer vaccine, GARDASIL
  by Marissa Heller
• Imiquimod 5% cream shows efficacy in treatment of Bowen's disease
  by Marissa Heller
• Gefitinib in treating patients undergoing surgery and/or radiation therapy for locally advanced or recurrent squamous cell skin cancer
• Comparing skin disinfectants before labor epidural analgesia
• A chemical look at benzoyl peroxide may prove helpful
  by Craig G. Burkhart
• Photodynamic therapy: practical cosmetic applications
  by Tina S. Alster
• Light, ice, or cream: nonexcisional approaches to squamous cell carcinoma in situ
  by Isaac Brownell
• Study finds calcipotriol/betamethasone dipropionate combination safe
  by Marissa Heller
• Biobank skin cancer: storing blood and protein of patients with skin cancer
• Skin structure infections with suspected or proven MRSA
• Prospective clinical evaluation of 1440-NM laser delivered by microarray for treatment of photoaging and scars
  by Robert A. Weiss
• A quantitative and comprehensive grading scale for rhytides, laxity, and photoaging
  by Macrene Alexiades-Armenakas
• Study shows efficacy of new treatment for molluscum contagiosum
  by Marissa Heller
• T4N5 liposomal lotion in preventing the recurrence of nonmelanoma skin cancer in patients who have undergone a kidney transplant
• Daptomycin in the treatment of patients with renal insufficiency and complicated skin and skin structure infections
• Monopolar radiofrequency facial tightening: a retrospective analysis of efficacy and safety in over 600 treatments
  by Robert A. Weiss
• Treatment considerations for inflammatory acne: clinical evidence for adapalene 0.1% in combination therapies
  by Diane M. Thiboutot
• Ranbaxy receives FDA approval to market doxycycline tablets
  by Marissa Heller
• Phase III clinical trial of Transacin for postherpetic neuralgia
  by Marissa Heller
• Tumorapa 1: efficacy of rapamycin in secondary prevention of skin cancers in kidney transplant recipients
• Atopic dermatitis-like skin disease in pediatric heart transplant patients
• Case reports: development of a keratoacanthoma after topical photodynamic therapy with 5-aminolevulinic acid
  by Elena Maydan
• CollaGenex Pharmaceuticals receives FDA approval for Oracea
  by Marissa Heller
• Comparison of telavancin and vancomycin for complicated skin and skin structure infections with a focus on methicillin-resistant Staphylococcus aureus
• Clinical usefulness of optical skin biopsy
• A letter from the Guest Editor
  by Michael H. Gold
• Nonablative skin resurfacing: the role of PDT
  by Ricardo Ruiz-Rodriguez
• More evidence for cyclophosphamide in treating systemic sclerosis
  by Isaac Brownell
• Study shows folic acid supplementation may decrease efficacy of methotrexate
  by Marissa Heller
• Celecoxib in preventing skin cancer
• Computer-based continuing education for doctors in examination and counseling of patients on skin cancer or weight control
• Author's errata
• Use of antibiotics in dermatologic surgery
  by Perry Robins
• FDA grants orphan drug designation for evaluation of CellCept in pemphigus vulgaris
  by Marissa Heller
• Phase II clinical trial of AN0128 for atopic dermatitis
  by Marissa Heller
• Study evaluating sirolimus in nonmelanoma skin cancer in kidney transplant recipients
• Photodynamic therapy in treating patients with skin cancer
• Combined 633-nm and 830-nm LED treatment of photoaging skin
  by David J. Goldberg
• Cancer risks and antibody-mediated TNF blockade
  by Isaac Brownell
• New medication for the treatment of seborrheic dermatitis in African Americans
  by Marissa Heller
• Photodynamic therapy using silicon phthalocyanine 4 in treating patients with actinic keratosis, Bowen's disease, skin cancer, or stage I or stage II mycosis fungoides
• Effect of bosentan on skin fibrosis in patients with systemic sclerosis
• Effect of controlled volumetric tissue heating with radiofrequency on cellulite and the subcutaneous tissue of the buttocks and thighs
  by Emilia del Pino
• Case reports: a novel skin cream containing a mixture of human growth factors and cytokines for the treatment of adverse events associated with photodynamic therapy
  by Michael H. Gold
• FDA approves Orapred ODT
  by Marissa Heller
• Ceftobiprole in the treatment of resistant Staphylococcus aureus skin and skin structure infections
• The effect of Efudex treatment on photoaged skin
• Hair removal for Fitzpatrick skin types V and VI using light and heat energy technology
  by Neil S. Sadick
• Orlando Dermatology & Aesthetic Conference
• Cynosure receives Health Canada approval to market Cynergy workstation
  by Marissa Heller
• Effect of solar-simulated ultraviolet radiation on gene expression in unprotected and sunscreen-protected skin of healthy adults with Fitzpatrick skin type II
• Study of cetuximab in squamous cell carcinoma of the skin expressing EGFR